Cresanto Global Limited has decided to shift its registered office from Uttar Pradesh to Maharashtra, a move subject to approval by shareholders and other statutory authorities. The Board of Directors approved this proposal along with the alteration of Clause II of the Memorandum of Association to reflect the change. This strategic shift aims to align the company's registered location with its corporate operations in Mumbai.

The Board meeting, held on July 23, 2026, also resulted in the appointment of Ms. Komal Bajaj as the Internal Auditor for the financial year 2026-27. Ms. Bajaj is an MBA professional with over a decade of experience in marketing and finance. Additionally, the Board approved the Report of Board of Directors for the Financial Year 2025-26 and finalized the logistics for the 34th Annual General Meeting, including the book closure dates.

Material related party transactions were approved under Section 188 of the Companies Act, 2013, and Regulation 23 of SEBI (LODR) Regulations, 2015. The approvals cover various transactions in the normal course of business, including sales, purchases, and corporate guarantees. These agreements will remain valid from the conclusion of the AGM in FY 26-27 until the AGM in FY 27-28.

The related parties involved are Cresanto India Private Limited, Cresanto Industries LLP, and Koriander Consultants LLP. These entities are controlled by common Key Management Personnel of the company. The transactions are expected to be conducted at terms generally prevalent in the industry segments where the company operates.

Related Party Transaction Details

Cresanto Global Limited , formerly known as Raymed Labs Limited, has announced a crucial board meeting scheduled for August 1, 2025. The meeting agenda includes several significant proposals that could impact the company's structure and governance.

Capital Reduction Proposal

One of the primary items on the agenda is the consideration of a proposal for the reduction of share capital. This proposal will be discussed in accordance with Section 66 of the Companies Act, 2013. If approved by the board, the capital reduction plan will still require further approvals from shareholders and the National Company Law Tribunal (NCLT).

Key Appointments

The board meeting will also address important appointments within the company:

Secretarial Auditor

The board will consider the appointment of M/s. Nidhi Bajaj & Associates, Practicing Company Secretaries, as the Secretarial Auditor. If approved, the firm will serve for a five-year term, from the conclusion of the upcoming Annual General Meeting (AGM) until the AGM to be held in 2030-31.

Internal Auditor

Ms. Komal Bajaj is proposed to be appointed as the Internal Auditor for the Financial Year 2025-2026, in compliance with Section 138(1) of the Companies Act, 2013.

Annual Report and AGM Preparations

The board will also focus on finalizing the annual report and AGM details:

• Approval of the Board of Directors' report for the Financial Year 2024-25, along with its annexures.
• Determination of the date, time, and venue for the upcoming Annual General Meeting.
• Setting the book closure date for the AGM.

The meeting is set to take place at the corporate office of Cresanto Global Limited. As per the company's regulatory filing, the board may also consider other business matters with the permission of the chair.

Investors and stakeholders of Cresanto Global Limited should keep an eye on the outcomes of this board meeting, as the decisions made could have significant implications for the company's future direction and structure.